MedTrace Logo

Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis

NCT01701466 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-05-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether NeoVIDERM is effective at preventing radiation dermatitis in patients receiving external beam radiation therapy to the head and neck or breast areas.

Conditions

Interventions

OTHER

Aveeno cream

Twice a day

OTHER

Flamazine cream

Twice a day, when there is dry desquamation

OTHER

NeoVIDERM cream

Three times a day

Sponsors & Collaborators

  • Avario Healthcare Inc.

    collaborator INDUSTRY

  • Sir Mortimer B. Davis - Jewish General Hospital

    lead OTHER

Principal Investigators

  • Te Vuong, MD · Jewish General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701466 on ClinicalTrials.gov